Quadient S.A. reiterated consolidated earnings guidance for the fiscal year 2022. For the year, the company's organic revenue growth confirmed above 2% compared to fiscal year 2021. Current EBIT organic growth confirmed at low to mid-single digit compared to fiscal year 2021.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
19.42 EUR | -0.61% | +3.41% | +1.04% |
May. 09 | Quadient wins US healthcare contracts | CF |
May. 09 | Quadient Wins New US Contracts for Communication Software in Q1 | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.04% | 730M | |
+4.03% | 15.72B | |
-4.94% | 9.24B | |
-0.03% | 7.11B | |
+14.81% | 5.39B | |
-44.81% | 4.59B | |
+7.10% | 2.89B | |
+0.50% | 2.31B | |
-16.86% | 2.28B | |
-19.00% | 1.98B |
- Stock Market
- Equities
- QDT Stock
- News Quadient S.A.
- Quadient S.A. Reiterates Consolidated Earnings Guidance for the Fiscal Year 2022